Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 6:22 PM View:  | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 13-Sep-24 | Sale | 33,080 | $2.57 | $84,946.10 | (< 1%) 3.45M to 3.41M | |
| 13-Sep-24 6:22 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 12-Sep-24 | Sale | 31,777 | $2.73 | $86,732.10 | (< 1%) 3.48M to 3.45M | |
| 11-Sep-24 6:23 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 11-Sep-24 | Sale | 31,376 | $2.62 | $82,227.10 | (< 1%) 3.51M to 3.48M | |
| 12-Sep-24 8:40 PM View: | Tyree James L Director | Genelux Corp (GNLX) | 11-Sep-24 | Sale (Planned) | 1,730 | $2.60 | $4,498.87 | (4%) 49.25K to 47.52K | |
| 11-Sep-24 6:23 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 10-Sep-24 | Sale | 20,384 | $2.51 | $51,182.20 | (< 1%) 3.53M to 3.51M | |
| 11-Sep-24 6:23 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 09-Sep-24 | Sale | 23,383 | $2.70 | $63,199.60 | (< 1%) 3.55M to 3.53M | |
| 06-Sep-24 5:08 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 03-Sep-24 | Sale | 42,818 | $2.09 | $89,613.80 | (1%) 3.6M to 3.55M | |
| 30-Aug-24 7:58 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 30-Aug-24 | Sale | 142,589 | $2.17 | $309,846.00 | (4%) 3.74M to 3.6M | |
| 30-Aug-24 7:58 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 29-Aug-24 | Sale | 107,045 | $1.98 | $211,960.00 | (3%) 3.85M to 3.74M | |
| 30-Aug-24 7:58 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 28-Aug-24 | Sale | 15,918 | $2.05 | $32,604.80 | (< 1%) 3.86M to 3.85M | |
| 27-Aug-24 7:23 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 27-Aug-24 | Sale | 51,630 | $2.11 | $108,862.00 | (1%) 3.91M to 3.86M | |
| 27-Aug-24 7:23 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 23-Aug-24 | Sale | 40,000 | $2.29 | $91,416.00 | (1%) 3.95M to 3.91M | |
| 05-Aug-24 6:34 PM View: | Smither John W Director | Genelux Corp (GNLX) | 01-Aug-24 | Grant | 39,541 | -- | -- | 300% 13.17K to 52.71K | |
| 05-Aug-24 6:36 PM View: | Mirabelli Mary Director | Genelux Corp (GNLX) | 01-Aug-24 | Grant | 39,541 | -- | -- | 317% 12.46K to 52.0K | |
| 05-Aug-24 6:35 PM View: | Thomas John Director | Genelux Corp (GNLX) | 01-Aug-24 | Grant | 39,541 | -- | -- | 8% 465.96K to 505.5K | |
| 05-Aug-24 6:37 PM View: | Tyree James L Director | Genelux Corp (GNLX) | 01-Aug-24 | Grant | 39,541 | -- | -- | 407% 9.71K to 49.25K | |
| 08-Jul-24 4:30 PM View: | Ryder Sean General Counsel | Genelux Corp (GNLX) | 24-Jun-24 | Sale | 5,496 | $2.12 | $11,651.50 | (22%) 24.88K to 19.39K | |
| 08-Jul-24 4:30 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 24-Jun-24 | Sale | 6,849 | $2.12 | $14,519.90 | (39%) 17.72K to 10.87K | |
| 07-Jun-24 9:45 PM View: | Thomas John Director | Genelux Corp (GNLX) | 29-May-24 | Purchase | 2,500 | -- | -- | < 1% 463.46K to 465.96K | |
| 07-Jun-24 9:40 PM View: | Ryder Sean General Counsel | Genelux Corp (GNLX) | 29-May-24 | Purchase | 10,000 | -- | -- | 1748% 0.57K to 10.57K | |
| 07-Jun-24 9:45 PM View: | Tyree James L Director | Genelux Corp (GNLX) | 29-May-24 | Purchase | 6,250 | -- | -- | 181% 3.46K to 9.71K | |
| 07-Jun-24 9:40 PM View: | Smalling Ralph Head of Regulatory | Genelux Corp (GNLX) | 29-May-24 | Purchase | 1,250 | -- | -- | 10% 12.06K to 13.31K | |
| 07-Jun-24 9:40 PM View: | Zak Lourie S. Chief Financial Officer | Genelux Corp (GNLX) | 29-May-24 | Purchase | 31,250 | -- | -- | 100% 0 to 31.25K | |
| 07-Jun-24 9:40 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 29-May-24 | Purchase | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 07-Jun-24 9:45 PM View: | Smither John W Director | Genelux Corp (GNLX) | 29-May-24 | Purchase | 6,250 | -- | -- | 90% 6.92K to 13.17K | |
| 07-Jun-24 9:40 PM View: | Zindrick Thomas President and CEO Director | Genelux Corp (GNLX) | 29-May-24 | Purchase | 200,000 | -- | -- | 1365% 14.65K to 214.65K | |
| 07-Jun-24 9:45 PM View: | Mirabelli Mary Director | Genelux Corp (GNLX) | 29-May-24 | Purchase | 8,000 | -- | -- | 179% 4.46K to 12.46K | |
| 15-May-24 5:59 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 15-May-24 | Sale | 17,094 | $3.66 | $62,623.90 | (< 1%) 3.97M to 3.95M | |
| 15-May-24 5:59 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 14-May-24 | Sale | 15,426 | $3.58 | $55,274.40 | (< 1%) 3.99M to 3.97M | |
| 15-May-24 5:59 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 13-May-24 | Sale | 3,446 | $3.62 | $12,478.30 | (< 1%) 3.99M to 3.99M | |
| 09-May-24 4:38 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 08-May-24 | Sale | 13,919 | $3.82 | $53,188.70 | (< 1%) 4.0M to 3.99M | |
| 09-May-24 4:38 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 07-May-24 | Sale | 6,025 | $3.67 | $22,111.10 | (< 1%) 4.01M to 4.0M | |
| 01-May-24 6:16 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 01-May-24 | Sale | 33,061 | $3.30 | $109,161.00 | (< 1%) 5.27M to 5.24M | |
| 01-May-24 6:16 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 30-Apr-24 | Sale | 20,535 | $3.12 | $63,980.90 | (< 1%) 5.29M to 5.27M | |
| 01-May-24 6:16 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 29-Apr-24 | Sale | 6,403 | $3.25 | $20,792.50 | (< 1%) 5.3M to 5.29M | |
| 24-Apr-24 5:50 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 24-Apr-24 | Sale | 8,064 | $3.50 | $28,250.60 | (< 1%) 4.08M to 4.07M | |
| 24-Apr-24 5:50 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 23-Apr-24 | Sale | 22,000 | $3.49 | $76,799.80 | (< 1%) 4.1M to 4.08M | |
| 24-Apr-24 5:50 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 22-Apr-24 | Sale | 14,331 | $3.53 | $50,597.00 | (< 1%) 4.11M to 4.1M | |
| 18-Apr-24 5:00 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 17-Apr-24 | Sale | 22,737 | $3.71 | $84,424.80 | (< 1%) 4.14M to 4.11M | |
| 18-Apr-24 5:00 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 16-Apr-24 | Sale | 48,683 | $3.53 | $171,802.00 | (1%) 4.19M to 4.14M | |
| 08-Jul-24 4:30 PM View: | Zindrick Thomas President and CEO Director | Genelux Corp (GNLX) | 14-Mar-24 | Grant | 26,264 | -- | -- | 110% 23.94K to 50.21K | |
| 08-Jul-24 4:30 PM View: | Ryder Sean General Counsel | Genelux Corp (GNLX) | 14-Mar-24 | Grant | 9,270 | -- | -- | 69% 13.51K to 22.78K | |
| 08-Jul-24 4:30 PM View: | Smalling Ralph Head of Regulatory | Genelux Corp (GNLX) | 14-Mar-24 | Grant | 2,107 | -- | -- | 13% 16.04K to 18.14K | |
| 08-Jul-24 4:30 PM View: | Zak Lourie S. Chief Financial Officer | Genelux Corp (GNLX) | 14-Mar-24 | Grant | 3,852 | -- | -- | 11% 34.58K to 38.43K | |
| 08-Jul-24 4:30 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 14-Mar-24 | Grant | 11,557 | -- | -- | 188% 6.16K to 17.72K | |
| 08-Jul-24 4:30 PM View: | Cappello Joseph VP, Pharmaceutical Development | Genelux Corp (GNLX) | 14-Mar-24 | Grant | 11,557 | -- | -- | 123% 9.4K to 20.95K | |
| 08-Jul-24 4:30 PM View: | Zindrick Thomas President and CEO Director | Genelux Corp (GNLX) | 19-Feb-24 | Grant | 8,320 | -- | -- | 57% 14.65K to 22.97K | |
| 08-Jul-24 4:30 PM View: | Ryder Sean General Counsel | Genelux Corp (GNLX) | 19-Feb-24 | Grant | 2,936 | -- | -- | 28% 10.57K to 13.51K | |
| 08-Jul-24 4:30 PM View: | Smalling Ralph Head of Regulatory | Genelux Corp (GNLX) | 19-Feb-24 | Grant | 616 | -- | -- | 5% 13.31K to 13.93K | |
| 08-Jul-24 4:30 PM View: | Zak Lourie S. Chief Financial Officer | Genelux Corp (GNLX) | 19-Feb-24 | Grant | 1,220 | -- | -- | 4% 31.25K to 32.47K |
